Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 127 entries
View as:

Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002654 Org: User:
Start: 04/30/94 End: 07/31/00 Due: 07/31/01

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003280 Org: User:
Start: 01/31/98 End: 03/31/02 Due: 03/31/03

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Phase: N/A Priority: Normal
NCT ID: NCT07020065 Org: User:
Start: 11/30/25 End: 03/31/30 Due: 03/31/31

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06090162 Org: User:
Start: 03/12/24 End: 12/31/26 Due: 12/31/27

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04245514 Org: User:
Start: 07/15/20 End: 12/31/31 Due: 12/31/32

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01107639 Org: User:
Start: 05/27/10 End: 12/09/18 Due: 12/09/19

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT02051218 Org: User:
Start: 07/16/14 End: 12/31/28 Due: 12/31/29

Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00234026 Org: User:
Start: 06/30/05 End: 03/31/06 Due: 03/31/07

Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02311543 Org: User:
Start: 03/18/15 End: 06/27/17 Due: 06/27/18

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

Phase: N/A Priority: Normal
NCT ID: NCT03937843 Org: User:
Start: 07/29/19 End: 12/31/46 Due: 12/31/47

Biological Therapy in Treating Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003779 Org: User:
Start: 11/30/98 End: 06/30/10 Due: 06/30/11

Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT04629781 Org: User:
Start: 05/28/21 End: 01/29/24 Due: 01/29/25

Adjuvant Aspirin Treatment for Colon Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02467582 Org: User:
Start: 06/09/16 End: 09/14/23 Due: 09/14/24

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01164709 Org: User:
Start: 07/31/10 End: 11/30/13 Due: 11/30/14

Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06114108 Org: User:
Start: 12/21/23 End: 11/01/27 Due: 11/01/28

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02451111 Org: User:
Start: 11/06/15 End: 07/15/23 Due: 07/15/24

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00238290 Org: User:
Start: 05/31/05 End: 04/30/11 Due: 04/30/12

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00227734 Org: User:
Start: 06/30/04 End: 02/28/06 Due: 02/28/07

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01272050 Org: User:
Start: 01/06/11 End: 05/31/24 Due: 05/31/25

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00072033 Org: User:
Start: 03/31/03 End: 05/31/10 Due: 05/31/11

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00392691 Org: User:
Start: 10/31/06 End: 05/31/13 Due: 05/31/14

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00004208 Org: User:
Start: 08/31/00 End: 10/31/11 Due: 10/31/12

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Phase: N/A Priority: Normal
NCT ID: NCT04472949 Org: User:
Start: 06/25/21 End: 12/31/27 Due: 12/31/28

Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02833766 Org: User:
Start: 10/28/16 End: 08/03/21 Due: 08/03/22

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Phase: N/A Priority: Normal
NCT ID: NCT04480372 Org: User:
Start: 03/17/21 End: 04/03/24 Due: 04/03/25